{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["d7770ffc-e2ff-418d-9434-8d570c4c7f56", "Q1", 20686, "JOHNSON & JOHNSON SERVICES, INC.", 126906, "JOHNSON & JOHNSON SERVICES INC", 2019, "first_quarter", "2019-04-22T14:26:16.577000-04:00", 1440000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/d7770ffc-e2ff-418d-9434-8d570c4c7f56/\", \"filing_uuid\": \"d7770ffc-e2ff-418d-9434-8d570c4c7f56\", \"filing_type\": \"Q1\", \"filing_type_display\": \"1st Quarter - Report\", \"filing_year\": 2019, \"filing_period\": \"first_quarter\", \"filing_period_display\": \"1st Quarter (Jan 1 - Mar 31)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/d7770ffc-e2ff-418d-9434-8d570c4c7f56/print/\", \"filing_document_content_type\": \"text/html\", \"income\": null, \"expenses\": \"1440000.00\", \"expenses_method\": \"a\", \"expenses_method_display\": \"Method A - Reporting amounts using LDA definitions only\", \"posted_by_name\": \"Jane Adams\", \"dt_posted\": \"2019-04-22T14:26:16.577000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"ONE JOHNSON & JOHNSON PLAZA\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"NEW BRUNSWICK\", \"registrant_state\": \"NJ\", \"registrant_zip\": \"08933\", \"registrant\": {\"id\": 20686, \"url\": \"https://lda.senate.gov/api/v1/registrants/20686/\", \"house_registrant_id\": 30348, \"name\": \"JOHNSON & JOHNSON SERVICES, INC.\", \"description\": null, \"address_1\": \"ONE JOHNSON & JOHNSON PLAZA\", \"address_2\": null, \"address_3\": null, \"address_4\": null, \"city\": \"NEW BRUNSWICK\", \"state\": \"NJ\", \"state_display\": \"New Jersey\", \"zip\": \"08933\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"JANE ADAMS\", \"contact_telephone\": \"+1 202-589-1000\", \"dt_updated\": \"2026-01-30T17:07:18.126576-05:00\"}, \"client\": {\"id\": 126906, \"url\": \"https://lda.senate.gov/api/v1/clients/126906/\", \"client_id\": 12, \"name\": \"JOHNSON & JOHNSON SERVICES INC\", \"general_description\": null, \"client_government_entity\": false, \"client_self_select\": true, \"state\": \"NJ\", \"state_display\": \"New Jersey\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": \"NJ\", \"ppb_state_display\": \"New Jersey\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2007-08-14\"}, \"lobbying_activities\": [{\"general_issue_code\": \"TRD\", \"general_issue_code_display\": \"Trade (domestic/foreign)\", \"description\": \"-Issues related to the NAFTA/USMCA renegotiation issues.\\n-Issues related to new tariff proclamations and retaliation.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 55206, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KAVANAUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"TAX\", \"general_issue_code_display\": \"Taxation/Internal Revenue Code\", \"description\": \"- Issues related to miscellaneous tax bills.\\n- Issues related to spending and linked to corporate tax rate\\n- H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions\\n- H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions\\n- Issues related to replacing G1LT1 global average method with a per country minimum.\\n- Issues related to CFC look through.\\n- Issues related to the Tax Cut and Jobs Act of 2017\\n- H.R. 1922/S. 1089 - A bill to amend the Internal Revenue Code of 1986 to repeal the amendments made by the Patient Protection and Affordable Care Act which disqualify expenses for over-the-counter drugs under health savings accounts and health flexible spending arrangements, regarding all provisions.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 18909, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"JANE\", \"nickname\": null, \"middle_name\": \"MARGARET\", \"last_name\": \"ADAMS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 55206, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KAVANAUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 4874, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"DARREL\", \"nickname\": null, \"middle_name\": \"C\", \"last_name\": \"JODREY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"HCR\", \"general_issue_code_display\": \"Health Issues\", \"description\": \"- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions\\n- S. 726 - Personal Care Products Safety Act, regarding all provisions\\n- H.R. 269 - Pandemic and All-Hazards Preparedness & Advancing Innovation Act of 2019, regarding all provisions\\n- Issues related to the reputation of over-the-counter drugs\\n- Issues related to cosmetic regulatory reform\\n- Issues related to cosmetic animal testing\\n- Issues related to biosimilars\\n- Issues related to maternal mortality\\n- Issues related to contact lens safety\\n- Issues related to the medical device tax repeal\\n- Issues related to medical product communications\\n- Issues related to medical product review\\n- Issues related to talc safety\\n- Issues related to drug pricing reform\\n- Issues related to diversity in clinical trials\\n- Issues related to health care pricing transparency\\n- Issues related to peripheral artery disease\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 139147, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"MEGHAN\", \"nickname\": null, \"middle_name\": \"DRENAN\", \"last_name\": \"STONE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 18909, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"JANE\", \"nickname\": null, \"middle_name\": \"MARGARET\", \"last_name\": \"ADAMS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 65730, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"ANNE\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRUCE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 50432, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"LAURYL\", \"nickname\": null, \"middle_name\": \"DODSON\", \"last_name\": \"JACKSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 4874, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"DARREL\", \"nickname\": null, \"middle_name\": \"C\", \"last_name\": \"JODREY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 55206, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KAVANAUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66287, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BARNARD\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 70494, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KELLY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WATERS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Legislative Correspondent, Office of Congressman Leonard Lance, June 2014 - January 2017.\", \"new\": true}, {\"lobbyist\": {\"id\": 70499, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"LEIF\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BRIERLEY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Winston Health Policy Fellow, Office of Senator Michael Bennet, September 2014 - July 2015.\", \"new\": true}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"VET\", \"general_issue_code_display\": \"Veterans\", \"description\": \"-Issues regarding Healthy Heroes, partnership with the VA on Suicide Prevention, integrated marketing, clinical trials and personalized medicine.\\n-Issues related to VA medical device procurement issues.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 18909, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"JANE\", \"nickname\": null, \"middle_name\": \"MARGARET\", \"last_name\": \"ADAMS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 70494, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KELLY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WATERS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"MMM\", \"general_issue_code_display\": \"Medicare/Medicaid\", \"description\": \"- Issues related to reimbursement\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 66287, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BARNARD\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"BUD\", \"general_issue_code_display\": \"Budget/Appropriations\", \"description\": \"-Issues related to FY2020 Appropriations, specifically the Special Olympics, The Global Fund, Food & Drug Administration, Commerce, Interior, and Environmental Protection Agency budgets.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 139147, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"MEGHAN\", \"nickname\": null, \"middle_name\": \"DRENAN\", \"last_name\": \"STONE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 50432, \"prefix\": \"ms\", \"prefix_display\": \"MS.\", \"first_name\": \"LAURYL\", \"nickname\": null, \"middle_name\": \"DODSON\", \"last_name\": \"JACKSON\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 4874, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"DARREL\", \"nickname\": null, \"middle_name\": \"C\", \"last_name\": \"JODREY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 18909, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"JANE\", \"nickname\": null, \"middle_name\": \"MARGARET\", \"last_name\": \"ADAMS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 66287, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"MICHAEL\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"BARNARD\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}, {\"lobbyist\": {\"id\": 70494, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"KELLY\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"WATERS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"CPT\", \"general_issue_code_display\": \"Copyright/Patent/Trademark\", \"description\": \"- Patent Trade Office reforms\\n- H.R.1520-Purple Book Continuity Act of 2019, regarding all provisions\\n- H.R.1503-Orange Book Transparency Act of 2019, regarding all provisions\\n- H.R.1499-Protecting Consumer Access to Generic Drugs Act of 2019, regarding all provisions\\n- S.649 -Biologic Patent Transparency Act, regarding all provisions.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 55206, \"prefix\": null, \"prefix_display\": null, \"first_name\": \"DAVID\", \"nickname\": null, \"middle_name\": null, \"last_name\": \"KAVANAUGH\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"ENV\", \"general_issue_code_display\": \"Environment/Superfund\", \"description\": \"- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 4874, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"DARREL\", \"nickname\": null, \"middle_name\": \"C\", \"last_name\": \"JODREY\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"TOR\", \"general_issue_code_display\": \"Torts\", \"description\": \"- Issues related to civil justice reform.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 18909, \"prefix\": \"mrs\", \"prefix_display\": \"MRS.\", \"first_name\": \"JANE\", \"nickname\": null, \"middle_name\": \"MARGARET\", \"last_name\": \"ADAMS\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": null, \"new\": false}], \"government_entities\": [{\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["d7770ffc-e2ff-418d-9434-8d570c4c7f56"], "units": {}, "query_ms": 2.2488890681415796, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}